Abrupt Versus Tapered Interruption of Chronic Clopidogrel Therapy After DES Implantation

NCT00640679 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

782

Enrollment

OTHER

Sponsor class

Stopped Due to slow enrollment the study was stopped prematurely.

Conditions

Coronary Artery Disease

Interventions

DRUG: Abrupt Clopidogrel Interruption
DRUG: Clopidogrel Tapering

Sponsor

Deutsches Herzzentrum Muenchen